Immunogenicity of a New Thermostable 17D Yellow Fever Vaccine
The vaccine for 17D yellow fever has proved to be very effective and well tolerated, and consequently has been recommended by WHO for travel to countries with yellow fever. A heat-stable preparation was developed to make vaccines suitable for use in endemic areas [1-4], where multidose presentations are mainly used in mass immunization campaigns.
Unable to display preview. Download preview PDF.
- 4.Tomori O, Fabiyi A (1983) Stability of Institut Pasteur 17D yellow fever vaccine. IPP-S-365. Conferénce Internationale sur les Vaccins Viraux et Bactériens, Institut Pasteur Production, 12–15 DecembreGoogle Scholar